GOTHENBURG, Sweden – Global health and wellness company Zinzino AB (publ) has announced its preliminary sales results for May 2026, reporting continued growth across several key markets. The company achieved a 14% increase in total group revenue compared to the same month last year, highlighting the strength of its expanding international business model and growing demand for personalized nutrition solutions.
According to the company’s latest sales report, revenue from Zinzino’s sales markets reached SEK 312.2 million in May 2026, compared to SEK 273.7 million during May 2025. Meanwhile, Faun Pharma generated external sales of SEK 3.9 million, unchanged from the previous year.
As a result, total group revenue increased by 14%, reaching SEK 316.1 million, compared to SEK 277.6 million in May 2025.
The company’s performance throughout the first five months of 2026 reflects sustained momentum across its global operations.
Between January and May 2026, accumulated group revenue increased by 23%, reaching SEK 1.55 billion, compared to SEK 1.25 billion during the same period in 2025.
Zinzino’s core business accounted for SEK 1.52 billion in year-to-date revenue, representing a 24% increase, while Faun Pharma contributed SEK 28.2 million, up 8% year over year.
The strong growth demonstrates the effectiveness of Zinzino’s direct-selling business model, international expansion strategy, and increasing consumer interest in personalized nutrition and wellness products.
One of the most notable highlights from the May 2026 report was the exceptional performance in North America.
Revenue in the region surged 44% year-over-year, reaching SEK 66.6 million in May. For the January-to-May period, North American revenue climbed 58%, totaling SEK 329.3 million.
The region, which includes the United States, Canada, and Mexico, has become one of Zinzino’s fastest-growing markets and a major contributor to the company’s overall expansion.
Central Europe also posted impressive gains during the month.
The region generated SEK 99.2 million in revenue during May, representing a 36% increase compared to the previous year. Year-to-date revenue reached SEK 464.4 million, up 39% from 2025.
Germany, Austria, and Switzerland continue to play a significant role in driving Zinzino’s European growth strategy.
Although still representing a smaller portion of overall sales, South America recorded the highest percentage growth among all regions.
Monthly revenue increased by an impressive 350%, while year-to-date revenue surged 379%. Markets such as Peru and Colombia continue to gain traction as awareness of personalized nutrition solutions expands across the region.
Several regions reported stable or moderate growth during the reporting period.
South & West Europe achieved a 7% increase in May revenue and a 19% increase year-to-date. Africa also continued its positive trajectory with 11% growth in May and 25% growth for the first five months of the year.
However, some markets experienced temporary declines. The Nordics reported an 11% decrease in May sales, while Eastern Europe, the Baltics, and Asia-Pacific saw modest reductions compared to the previous year.
Despite these regional fluctuations, Zinzino’s overall global performance remained strong due to significant growth in its largest and fastest-expanding markets.
Zinzino has continued strengthening its global position through a series of strategic acquisitions in the health and wellness sector.
The company has acquired the assets of several well-known direct-selling brands, including It Works!, Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita, Xelliss, and Sanki Global.
These acquisitions have expanded Zinzino’s international distribution network and increased its access to new customer bases across multiple markets.
Zinzino AB (publ) is a Scandinavian-based global direct-sales company specializing in test-based personalized nutrition and scientific skincare solutions. The company is publicly traded on the Nasdaq First North Premier Growth Market under the ticker symbol ZZ-B.ST.
Zinzino’s scientifically validated nutritional supplements are available in more than 100 markets worldwide. In addition to its wellness portfolio, the company owns skincare brand HANZZ+HEIDII, Norwegian research and production companies BioActive Foods AS and Faun Pharma AS, and co-owns Cypriot olive oil producer Cleanthi Alpha-Olenic LTD.
Headquartered in Gothenburg, Sweden, Zinzino continues to expand its global presence through innovation, strategic acquisitions, and growing consumer demand for personalized health and wellness solutions.
As Zinzino progresses through 2026, the company remains well-positioned to capitalize on rising global demand for personalized nutrition, scientific wellness products, and direct-selling opportunities across international markets.
There are no reviews yet. Be the first one to write one.
